3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Melanoma
49
Carcinoma, Basal Cell
12
Neoplasm Metastasis
9
Lymphoma, T-Cell, Cutaneous
9
Skin Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Lymphoma, T-Cell
5
Colorectal Neoplasms
5
Carcinoma, Merkel Cell
5
Uveal Melanoma
4
Uterine Cervical Neoplasms
4
Mycosis Fungoides
4
Lymphoma
4
Lung Neoplasms
4
Carcinoma, Renal Cell
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Follicular
3
Keratosis, Actinic
3
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Sezary Syndrome
2
Prostatic Neoplasms
2
Interventions
pembrolizumab
27
Nivolumab
20
atezolizumab
6
Ipilimumab
6
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Paclitaxel
4
Docetaxel
4
Cyclophosphamide
4
Carboplatin
4
fludarabine
3
avelumab
3
Pemetrexed
3
Interleukin-2
3
tislelizumab
2
epacadostat
2
durvalumab
2
aldesleukin
2
Taxes
2
Radiosurgery
2
Cisplatin
2
veliparib
1
toripalimab
1
spartalizumab
1
sotigalimab
1
sonidegib
1
sargramostim
1
regorafenib
1
poly ICLC
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Biopsy
×
Dermatologic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled